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E. Gijs Mast, MD,* Thom L. De Kroon, MD,† Jurriën M. ten Berg, MD, PHD*
Nieuwegein, the NetherlandsIn patients with severe aortic valve stenosis and
high risk for surgery, transcatheter aortic valve
implantation is emerging as a true alternative for
open replacement (1).
We report the first case of direct transaortic
valve-in-valve implantation of a CoreValve in an
insufficient Sapien valve (Edwards Lifesciences,
Inc., Irvine, California).
An 87-year-old patient with a history of carci-
noma and severe peripheral vascular disease re-
ceived a 26-mm Edwards Sapien bioprosthesis by
uncomplicated transapical procedure. Echocardi-
ography 1 week after implantation showed no
significant aortic valve insufficiency.
During follow-up, however, symptoms per-
sisted. Echocardiography 10 months after im-
plantation showed good position of the Sapien
valve but now moderate-to-severe central insuf-
ficiency and moderate ventricular function. Be-
cause the apex was already used and both sub-
clavian arteries were too small, we decided to
perform a redo transcatheter aortic valve implan-
tation with a CoreValve prosthesis by direct
aortic access.
After partial upper sternotomy, the aorta was
adequately exposed. Double purse-string sutures
were placed on the anterior aspect of the distal
ascending aorta before introducing the 18-F sheath
directly. After introducing the stiff guidewire, a
26-mm CoreValve prosthesis was positioned and
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(Fig. 1). Control angiography and echocardiogra-
phy showed only minor paravalvular leakage. Re-
covery was uneventful.
The mechanism of Sapien valve failure in our
patient remains unclear. Al-Attar et al. (2) have
suggested irregular deployment of the stent as a
possible explanation of regurgitation. Leaflet injury
due to balloon dilation after stent deployment has
also been suggested as a cause for failure (3). Both
seem unlikely in our patient, because initially the
valve functioned adequately without leakage after a
successful implant.
Direct aortic access might be a useful alternative
Figure 1. CoreValve in Sapien Valve
Coronary angiography at the end of the procedure showing
the 26-mm CoreValve prosthesis (Edwards Lifesciences, Inc.,
Irvine, California) deployed at the intended position inside
the Sapien valve, with direct aortic access.to transfemoral, -subclavian, and -apical approach.
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1050Due to the short distance to the valve, positioning of the
valve is much easier.
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